Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

ConditionGlaucoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione G.B. Bietti, IRCCS

About this trial

The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness

Disqualifiers

age<18 years

unable to read, understand and sign the written informed consent

unable to perform visual field test

advanced glaucoma with C/D>0.7

Trial population

glaucoma patients referring to glaucoma clinic of IRCCS-Fondazione GB Bietti and University of Rome Tor Vergata.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

the agreement between 10-2 HFA and 24-2c HFA in detecting central visual field defect

central visual field is defined by the presence of a cluster of three test locations with significantly reduced sensitivity in a hemifield fo the pattern deviation plot.

Time frame
12 month

Secondary outcomes

1

the agreement between 24-2c HFA and G1 Octopus in detecting central visual field defect

central visual field is defined by the presence of a cluster of three test locations with significantly reduced sensitivity in a hemifield fo the pattern deviation plot.

Time frame
12 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.